NDVAF - Indiva Limited
| Previous Close | 0.1500 |
| Open | 0.1510 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.1510 - 0.1510 |
| 52 Week Range | 0.1140 - 0.4220 |
| Volume | 831 |
| Avg. Volume | 51,419 |
| Market Cap | 12.523M |
| Beta (5Y Monthly) | 1.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0930 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
INDIVA ANNOUNCES AMENDMENT AND EXPANSION TO LICENCE AND PROVIDES CORPORATE UPDATE
Today, Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is announcing that Health Canada has approved its licence amendment, adding 10,000 square feet of production space. The newly licensed space adds additional capacity for production of Bhang® Chocolate, Wana Sour Gummies and other Powered by INDIVA™ products. It also provides licensed space for Indiva to begin extraction operations.
- GlobeNewswire
Indiva Partners With Award-Winning Wana Brands, Inc.
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is excited to announce that it has partnered with award-winning Wana Brands (“Wana”) to bring their innovative cannabis-infused products to Canada. Wana is the premiere U.S. edibles company with more dollars sold than any other brand according to BDS Analytics’ 2019 Brand Share Report. Currently available in Arizona, California, Colorado, Illinois, Michigan, Ohio and Oregon, Wana is teaming up with Indiva to enter its first international market.
- GlobeNewswire
Indiva and Lift & Co. Release Branded CannSell Education Module
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) and Lift & Co. Corp. (“Lift & Co.”) (LIFT.V) (LFCOF) are pleased to announce the release of Indiva’s CannSell branded education module. The CannSell certification program, created by Lift & Co., in exclusive partnership with MADD Canada, is currently utilized in eight Canadian jurisdictions. CannSell also serves as the provincially-mandated training program for all cannabis retail workers in Ontario.
- GlobeNewswire
Indiva Finalizes White-Label Licensing and Manufacturing Agreement With Dycar Pharmaceuticals Ltd. and Grants Options
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that further to its press release dated December 11, 2019, the Company has entered into a licensing and manufacturing agreement (the "Agreement") with Dycar Pharmaceuticals Ltd. ("Dycar"). Pursuant to the Agreement, Dycar will immediately provide Indiva with non-dilutive financing of $3.6 million, $500,000 of which has been previously advanced, and an additional $4.5 million of non-dilutive financing over two instalments. Such amounts will be used to finance the production and distribution, by Indiva, of certain Dycar-branded cannabis products (the "Dycar Products").
- Baystreet
TSX Opens Flat Amid Continued Virus Scare
Canada's main stock index was flat on Friday as gains in energy stocks were offset by broader caution ...
- GlobeNewswire
Bhang Inc. Milk and Dark Chocolate Now Available in Canada
As previously announced in April 2018, Indiva and Bhang have a 50/50 joint venture to produce and distribute Bhang Chocolate. Through the joint venture, Indiva creates Bhang Chocolate in its state-of-the-art facility based in London, Ontario.
- GlobeNewswire
Indiva Closes The Previously Announced $1,500,000 Unsecured Convertible Debenture Offering
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that further to its news release dated January 31, 2020, it has closed the non-brokered private placement of unsecured convertible debentures (the “Debentures”) in the aggregate principal amount of $1,500,000 (the “Offering”). As previously announced in the Company's January 31, 2020, news release, the Debentures will mature on the date that is 36 months from the date of issuance, bear interest at the rate of 10% per annum, computed on the basis of a 360-day year composed of twelve 30-day months, and payable semi-annually on the last day of June and December of each year, commencing on June 30, 2020. The Debentures will be issued at a price of $1,000 per Debenture with each Debenture being convertible, at the option of the holder, into 4,000 common shares in the capital of the Company (each, a “Share”) at a conversion price of $0.25 per Share, subject to adjustments.
- GlobeNewswire
Indiva Receives Edibles, Extracts and Topicals Sales Licence From Health Canada
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that it has received its edibles, extracts and topicals sales licence from Health Canada. This approval enables the Company to deliver extracts, capsules and its portfolio of award-winning edibles to Canadians.
- GlobeNewswire
Indiva to Raise an Additional $1,500,000 in Unsecured Convertible Debentures
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that Prairie Merchant Corporation ("PMC") and another entity, both controlled or affiliated with W. Brett Wilson, have agreed to purchase unsecured convertible debentures ("Debentures") of the Company in the aggregate principal amount of $1,500,000 (the "Proceeds"). This is in addition to the Mr. Wilson’s previous existing shareholdings of Indiva and the $500,000 aggregate principal amount of unsecured convertible debentures purchased by PMC in the previously completed unsecured convertible debenture offering of the Company.
- Simply Wall St.
If You Had Bought Indiva (CVE:NDVA) Stock A Year Ago, You'd Be Sitting On A 33% Loss, Today
Indiva Limited (CVE:NDVA) shareholders should be happy to see the share price up 15% in the last week. But that...
- GlobeNewswire
Indiva Closes Final Tranche of Its Unsecured Convertible Debenture Offering
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that further to its news release dated December 9, 2019, and December 23, 2019, it has closed the second and final tranche of its non-brokered private placement of unsecured convertible debentures (the “Debentures”) in the aggregate principal amount of $1,040,000 (the “Final Tranche”). As previously announced in the Company's December 9, 2019, news release, the Debentures will mature on the date that is 36 months from the date of issuance, bear interest at the rate of 10% per annum, computed on the basis of a 360-day year composed of twelve 30-day months, and payable semi-annually on the last day of June and December of each year, commencing on June 30, 2020.
- GlobeNewswire
Indiva Delivers First Shipment of Cannabis to Quebec
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that it has delivered its first batch of premium cannabis products to the Société québécoise du cannabis ("SQDC"). Included in this shipment are White Russian and Jack Herer dry flower and pre-rolls. “We are pleased to deliver the first of many shipments to la belle province,” Niel Marotta, Indiva’s President and Chief Executive Officer, said.
- GlobeNewswire
Indiva Ships Sugarleaf by 7AC Pre-Rolls Nationwide
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that it has shipped its first cases of Sugarleaf by 7AC (“Sugarleaf”). In October 2019, Indiva announced that it had signed a definitive agreement (the "Agreement") with The Supreme Cannabis Company, Inc. (“Supreme Cannabis”) (FIRE.TO) (SPRWF) (53S1.F) to manufacture and distribute pre-rolls for Supreme Cannabis’ portfolio of brands from Indiva’s facility in London, Ontario. Sugarleaf’s rolled Jack Haze is the first product shipped under the Agreement.
- GlobeNewswire
Indiva Closes First Tranche of $4 Million Financing
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce the closing of the first tranche of its non-brokered private placement of unsecured convertible debentures (the “Debentures”) in the aggregate principal amount of $2,115,000, which forms part of its larger offering of up to the aggregate principal amount of $4,000,000 Debentures (the “Offering”). As previously announced in the Company's December 9, 2019, news release, the Debentures will mature on the date that is 36 months from the date of issuance, bear interest at the rate of 10% per annum, computed on the basis of a 360-day year composed of twelve 30-day months, and payable semi-annually on the last day of June and December of each year, commencing on June 30, 2020.
- GlobeNewswire
Indiva Ships Jack Herer to Ontario Cannabis Store
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that it has shipped Jack Herer pre-rolls to the Ontario Cannabis Store. Jack Herer, named for the marijuana activist and author, is a much-beloved sativa-dominant strain. Grown in Indiva’s state-of-the-art facility based in London, Ontario, INDIVA™ Jack Herer is available in 0.5 g pre-rolls with two units per pack.
- GlobeNewswire
Indiva Completes First Shipment of Pre-Rolls to Saskatchewan
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce that its wholly-owned subsidiary, Indiva Inc., has completed its first shipment of cannabis to Saskatchewan. This shipment marks another significant step in Indiva becoming a national provider of premium cannabis products. INDIVA™ hand-finished pre-rolls will be available for purchase at Saskatoon’s The Pot Shack within the next few weeks.
- GlobeNewswire
Indiva Announces White-Label Partnership With Dycar Pharmaceuticals Ltd. and Unsecured Convertible Debenture Financing Up to $4 Million
Indiva Limited (the “Company” or “Indiva”) (NDVA.V) (NDVAF) is pleased to announce a strategic partnership with Dycar Pharmaceuticals Ltd. (“Dycar”) and a concurrent non-brokered unsecured convertible debenture financing of up to $4 million. Indiva has entered into a financing and white-label manufacturing arrangement with Dycar. Under the terms of the letter agreement, Dycar will provide Indiva with initial non-dilutive financing of $3.1 million, and Indiva will manufacture and distribute certain Dycar-branded cannabis products from the Company’s licensed facility in London, Ontario.
CNW GroupIndiva Reports Third Quarter Fiscal 2019 Results
Indiva Reports Third Quarter Fiscal 2019 Results
CNW GroupIndiva Announces Proposed Amendment and Repricing of Outstanding Warrants & Update on Corporate Secretary
LONDON, ON , Nov. 15, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) is announcing that it is applying to the TSX Venture Exchange (the "Exchange") for approval to amend the terms of an aggregate of 9,429,896 outstanding common share purchase warrants (the "Warrants") issued in connection with the Company's "reverse takeover" transaction, which was completed on December 15, 2017 . The Warrants are exercisable into common shares in the capital of the Company at an exercise price of $0.90 per common share and are set to expire on December 13, 2019 . Under the proposed amendment to the Warrants (the "Proposed Amendment"), the Company will reduce the exercise price of the Warrants from $0.90 to $0.75 and extend the expiry date of the Warrants from December 13, 2019 to December 13, 2020 .
CNW GroupIndiva Announces Pre-Roll Partnership with the Supreme Cannabis Company, Inc.
LONDON, ON, Oct. 22, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA.V - News) (OTCQX:NDVAF - News) is pleased to announce it has signed a definitive agreement with The Supreme Cannabis Company, Inc. ("Supreme Cannabis") (TSX:FIRE.TO - News) (OTCQX:SPRWF - News) (FRA:53S1.F - News) to manufacture and distribute pre-rolls for Supreme Cannabis' portfolio of brands from Indiva's facility in London, Ontario. The Supreme Cannabis portfolio includes recognized premium recreational and wellness brands like 7ACRES, Blissco and KKE. "This partnership truly represents the best of Canada's cannabis industry.
- Simply Wall St.
Have Insiders Been Buying Indiva Limited (CVE:NDVA) Shares?
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
CNW GroupIndiva Announces Expansion Approval From Health Canada
LONDON, ON, Oct. 21, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA.V - News) (OTCQX:NDVAF - News) is pleased to announce that Health Canada has approved its licence amendment, adding 10,000 square feet of production space, including three new grow rooms and two additional processing rooms. This additional square footage will, subject to applicable regulatory approvals, be used to manufacture edibles, increase Indiva's flower production capacity, and enable new growth in the production, manufacturing, processing and refinement arms of the business. This new space significantly increases Indiva's revenue potential by adding more capacity to our production, processing and refinement operations," Niel Marotta, Indiva's President and Chief Executive Officer, said.
